Immunity in leukemia.
D000406:AKR murine leukemia virus / Q000276:immunology; D000818:Animals; D000912:Antibodies, Neoplasm; D000918:Antibody Specificity; D000961:Antilymphocyte Serum; D001260:Ataxia Telangiectasia / Q000150:complications; D001402:B-Lymphocytes / Q000276:immunology; D003601:Cytotoxicity Tests, Immunologic; D005622:Friend murine leukemia virus / Q000276:immunology; D006649:Histocompatibility Antigens; D006801:Humans; D007106:Immune Sera; D007153:Immunologic Deficiency Syndromes / Q000150:complications*; D007518:Isoantibodies; D007938:Leukemia / Q000209:etiology / Q000276:immunology*; D007945:Leukemia, Lymphoid / Q000276:immunology; D015470:Leukemia, Myeloid, Acute / Q000276:immunology; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D011817:Rabbits / Q000276:immunology; D011830:Radiation Effects; D013045:Species Specificity; D013154:Spleen / Q000528:radiation effects; D013601:T-Lymphocytes / Q000276:immunology
D000912:Antibodies, Neoplasm; D000961:Antilymphocyte Serum; D006649:Histocompatibility Antigens; D007106:Immune Sera; D007518:Isoantibodies